Skip to main content
Explore URMC

Wilmot Cancer Institute Logo

menu
Lymphoma: Targeting treatment for special populations

Lymphoma: Targeting treatment for special populations

Patrick Reagan, M.D., is working with Wilmot's Geriatric Oncology team, to develop a targeted approach for treating older adults with diffuse large B-cell lymphoma.

Gene Study Points Researchers toward New Pathway for Leukemia

Gene Study Points Researchers toward New Pathway for Leukemia

Leukemia is one of the hardest cancers to treat, but scientists have discovered a new, targetable pathway in one of the worst subtypes of the disease.

With Fresh Perspectives, Research Team Studies Needs of Older Patients

With Fresh Perspectives, Research Team Studies Needs of Older Patients

Wilmot researchers are taking on a wide variety of investigations all under the umbrella of “cancer and aging,” including studies of biomarkers for aging, the way aging cells respond to the stressful assault of cancer treatment, and how to use decision-making tools to help older patients prioritize their concerns and make trade-offs when it comes to treatment.

Building Bridges: Researchers Link to Community

Building Bridges: Researchers Link to Community

As researchers in Wilmot’s Cancer Control and Survivorship Program, Charles Kamen, Ph.D., and Matt Asare, Ph.D., have been focusing on the best ways to deliver clinical trials to underserved patients and minorities, and to educate cancer patients everywhere about clinical research.  Their goal is to design studies that are accessible to people in all types of communities, from center cities to rural outposts.

Hot Topic: Manipulating Cell Metabolism to Attack Cancer

Hot Topic: Manipulating Cell Metabolism to Attack Cancer

Wilmot scientists have identified cancer-causing mutations that control and alter the way cancer cells biosynthesize and replicate.

12